现代名老中医诊疗肺痨常见证候及其特征研究

Diagnosis and Treatment Study of Lung Consumption Common Syndromes and Characteristics from Modern Famous Veteran Doctors in Chinese Medicine

目的:基于现代百余年名老中医诊治肺痨的文献资料,挖掘肺痨常见证候及其临床特征。方法:选择已建立的《现代名老中医肺病数据库》、《期刊中医肺病数据库》,从中检索出符合纳入标准的文献,建立《现代名老中医诊治肺痨文献研究数据库》,利用SPSS22.0软件,采用频数描述、因子分析与聚类分析进行统计分析。结果:筛选出肺痨证候17种,频率≥5%的证候有6种:肺阴虚证、阴虚火旺证、肺气阴两虚证、肺肾阴虚证、肺脾气阴两虚证、肺气虚证。根据常见症状的因子分析与聚类分析结果所推断出的证候有:肺阴虚证、阴虚火旺证、肺气阴两虚证、肺肾阴虚证、肺脾气阴两虚证、肺气虚证,每个证候有其症状特征。结论:肺痨的临床常见证候有肺阴虚证、阴虚火旺证、肺气阴两虚证、肺肾阴虚证、肺脾气阴两虚证、肺气虚证,证候属性有一定规律,本研究结果尚需进一步的临床研究验证。

Objective： To find out common syndromes of lung consumption and its clinical characteristics based on the literature material of diagnosis and treatment methods of over a hundred modern famous veteran doctors in Chinese medicine.Methods： Retrieve the literature in accordance with inclusive criteria based on the Pulmonary Diseases Database of Modern Famous Veteran Doctors in Chinese Medicine and Pulmonary Diseases Periodicals Database in Chinese Medicine to build a Literature Study Database on Diagnosis and Treatment of Lung Consumption by Modern Famous Veteran Doctors in Chinese Medicine. Apply SPSS22.0 software to statistical analysis, with frequency description, factor analysis and cluster analysis.Results： Screened out 17 kinds of lung consumption syndromes, with 6 of them whose frequency≥5% such as lung yin deficiency, vigorous fire due to yin deficiency, deficiency of both qi and yin of lung, lung-kidney yin deficiency, deficiency of both qi and yin of lung and spleen and lung qi deficiency. Syndromes inferred from the factor and cluster analysis of common symptoms were the same as above, and each had its own symptom characteristics. Conclusions： Common clinical syndromes of lung consumption are lung yin deficiency, vigorous fire due to yin deficiency, deficiency of both qi and yin of lung,lung-kidney yin deficiency, deficiency of both qi and yin of lung and spleen and lung qi deficiency. The syndrome property has certain patterns but the results of the paper still need to be verified by further clinical studies.